Be A Freedom Fighter · Bill Library
HR 10954 — Don't Flush Babies Act
Freedom score: -7 (scale −10 to +10)
- Individual rights: -2
- Property rights: 0
- Economic freedom: -2
- Privacy & due process: -1
- Government power: -2
Sponsor: Rep. Biggs, Sheri [R-SC-3] · Latest action: Referred to the House Committee on Energy and Commerce. (2026-11-05)
Full text on GovInfo (introduced version) · Congress.gov · ← Bill Library index
Findings — 21 highlighted provisions
Each item below is one provision documented in the findings file. The same provision is highlighted in the full text underneath, with its section citation and criterion. Everything else on this page is plain, unreviewed bill text.
- Sec. 4(a)(1)–(4) · Individual Rights — Abortion-drug providers must provide collection kits/instructions, obtain receipt acknowledgment, accept returned remains and waste and arrange burial/cremation and disposal; patients affected but not expressly required to return remains See in text ↓
- Sec. 4(c)(1)–(2) · Individual Rights — Provider must accept returns even from nonpatients See in text ↓
- Sec. 5 · Individual Rights — Existing emergency-treatment requirements preserved See in text ↓
- Sec. 4(d) · Individual Rights — Provider/kit-tampering violations carry imprisonment/fines See in text ↓
- Sec. 4(a)–(e) · Property Rights — Regulates handling of biological material, not title or eminent domain See in text ↓
- Sec. 3, new FDCA §502(hh)(1)(A)–(C) · Economic Freedom — Abortion-drug packaging misbranded absent warning against flushing remains/waste, pictogram and gestational-development/consultation text See in text ↓
- Sec. 3, new §502(hh)(2) · Economic Freedom — Prominent readable high-contrast display See in text ↓
- Sec. 3, new §502(hh)(3)(A)–(F) · Economic Freedom — Defines abortion, covered drugs, fetus, fetal remains, packaging and waste, excluding miscarriage, ectopic/molar treatment and live-birth purposes See in text ↓
- Sec. 4(a)(1)–(4) · Economic Freedom — Kit, acknowledgment and disposal duties See in text ↓
- Sec. 4(b)(1)–(2) · Economic Freedom — Documentation identifies nearest receiving facility with contacts and approximate distance from patient address See in text ↓
- Sec. 4(c)(1)–(2) · Economic Freedom — Accepts returns regardless of patient relationship See in text ↓
- Sec. 4(d) · Economic Freedom — Up to five years imprisonment and $20,000–$150,000 fine per offense, or both, for covered dispensing without kit/documentation or tampering See in text ↓
- Sec. 4(e)(1)–(3) · Economic Freedom — Defines provider and kit components, separate leak-resistant containers, instructions, in-person returns and mail prohibition See in text ↓
- Sec. 4(a)(2) · Privacy and Due Process — Provider retains physical/electronic patient receipt acknowledgment See in text ↓
- Sec. 4(b)(2) · Privacy and Due Process — Address-dependent facility details See in text ↓
- Sec. 4(d) · Privacy and Due Process — Criminal penalties, without new special hearing or burden-of-proof rule See in text ↓
- Sec. 3, new FDCA §502(hh) · Government Power — New federal misbranding conditions See in text ↓
- Sec. 4(a) · Government Power — HHS directs provider procedures See in text ↓
- Sec. 4(d) · Government Power — Criminal fines/imprisonment See in text ↓
- Sec. 5 · Government Power — Preserves emergency care laws See in text ↓
- Sec. 6 · Government Power — Packaging rule applies to drugs packaged 180 days after enactment; no express delay for Sec. 4. No sunset See in text ↓
Full text (introduced version)
30 of 35 text blocks highlighted. Source: GovInfo, fetched cached.
SECTION 1. SHORT TITLE.
SEC. 2. FINDINGS.
SEC. 3. ABORTION DRUG WARNING LABEL REQUIREMENTS.
Sec. 3, new FDCA §502(hh)(1)(A)–(C) · Economic Freedom — Abortion-drug packaging misbranded absent warning against flushing remains/waste, pictogram and gestational-development/consultation text
Sec. 3, new §502(hh)(2) · Economic Freedom — Prominent readable high-contrast display
Sec. 3, new §502(hh)(3)(A)–(F) · Economic Freedom — Defines abortion, covered drugs, fetus, fetal remains, packaging and waste, excluding miscarriage, ectopic/molar treatment and live-birth purposes
Sec. 3, new FDCA §502(hh) · Government Power — New federal misbranding conditions
Sec. 3, new FDCA §502(hh)(1)(A)–(C) · Economic Freedom — Abortion-drug packaging misbranded absent warning against flushing remains/waste, pictogram and gestational-development/consultation text
Sec. 3, new §502(hh)(2) · Economic Freedom — Prominent readable high-contrast display
Sec. 3, new §502(hh)(3)(A)–(F) · Economic Freedom — Defines abortion, covered drugs, fetus, fetal remains, packaging and waste, excluding miscarriage, ectopic/molar treatment and live-birth purposes
Sec. 3, new FDCA §502(hh) · Government Power — New federal misbranding conditions
Sec. 3, new FDCA §502(hh)(1)(A)–(C) · Economic Freedom — Abortion-drug packaging misbranded absent warning against flushing remains/waste, pictogram and gestational-development/consultation text
Sec. 3, new §502(hh)(2) · Economic Freedom — Prominent readable high-contrast display
Sec. 3, new §502(hh)(3)(A)–(F) · Economic Freedom — Defines abortion, covered drugs, fetus, fetal remains, packaging and waste, excluding miscarriage, ectopic/molar treatment and live-birth purposes
Sec. 3, new FDCA §502(hh) · Government Power — New federal misbranding conditions
Sec. 3, new FDCA §502(hh)(1)(A)–(C) · Economic Freedom — Abortion-drug packaging misbranded absent warning against flushing remains/waste, pictogram and gestational-development/consultation text
Sec. 3, new §502(hh)(2) · Economic Freedom — Prominent readable high-contrast display
Sec. 3, new §502(hh)(3)(A)–(F) · Economic Freedom — Defines abortion, covered drugs, fetus, fetal remains, packaging and waste, excluding miscarriage, ectopic/molar treatment and live-birth purposes
Sec. 3, new FDCA §502(hh) · Government Power — New federal misbranding conditions
Sec. 3, new FDCA §502(hh)(1)(A)–(C) · Economic Freedom — Abortion-drug packaging misbranded absent warning against flushing remains/waste, pictogram and gestational-development/consultation text
Sec. 3, new §502(hh)(2) · Economic Freedom — Prominent readable high-contrast display
Sec. 3, new §502(hh)(3)(A)–(F) · Economic Freedom — Defines abortion, covered drugs, fetus, fetal remains, packaging and waste, excluding miscarriage, ectopic/molar treatment and live-birth purposes
Sec. 3, new FDCA §502(hh) · Government Power — New federal misbranding conditions
Sec. 3, new FDCA §502(hh)(1)(A)–(C) · Economic Freedom — Abortion-drug packaging misbranded absent warning against flushing remains/waste, pictogram and gestational-development/consultation text
Sec. 3, new §502(hh)(2) · Economic Freedom — Prominent readable high-contrast display
Sec. 3, new §502(hh)(3)(A)–(F) · Economic Freedom — Defines abortion, covered drugs, fetus, fetal remains, packaging and waste, excluding miscarriage, ectopic/molar treatment and live-birth purposes
Sec. 3, new FDCA §502(hh) · Government Power — New federal misbranding conditions
Sec. 3, new FDCA §502(hh)(1)(A)–(C) · Economic Freedom — Abortion-drug packaging misbranded absent warning against flushing remains/waste, pictogram and gestational-development/consultation text
Sec. 3, new §502(hh)(2) · Economic Freedom — Prominent readable high-contrast display
Sec. 3, new §502(hh)(3)(A)–(F) · Economic Freedom — Defines abortion, covered drugs, fetus, fetal remains, packaging and waste, excluding miscarriage, ectopic/molar treatment and live-birth purposes
Sec. 3, new FDCA §502(hh) · Government Power — New federal misbranding conditions
Sec. 3, new FDCA §502(hh)(1)(A)–(C) · Economic Freedom — Abortion-drug packaging misbranded absent warning against flushing remains/waste, pictogram and gestational-development/consultation text
Sec. 3, new §502(hh)(2) · Economic Freedom — Prominent readable high-contrast display
Sec. 3, new §502(hh)(3)(A)–(F) · Economic Freedom — Defines abortion, covered drugs, fetus, fetal remains, packaging and waste, excluding miscarriage, ectopic/molar treatment and live-birth purposes
Sec. 3, new FDCA §502(hh) · Government Power — New federal misbranding conditions
Sec. 3, new FDCA §502(hh)(1)(A)–(C) · Economic Freedom — Abortion-drug packaging misbranded absent warning against flushing remains/waste, pictogram and gestational-development/consultation text
Sec. 3, new §502(hh)(2) · Economic Freedom — Prominent readable high-contrast display
Sec. 3, new §502(hh)(3)(A)–(F) · Economic Freedom — Defines abortion, covered drugs, fetus, fetal remains, packaging and waste, excluding miscarriage, ectopic/molar treatment and live-birth purposes
Sec. 3, new FDCA §502(hh) · Government Power — New federal misbranding conditions
Sec. 3, new FDCA §502(hh)(1)(A)–(C) · Economic Freedom — Abortion-drug packaging misbranded absent warning against flushing remains/waste, pictogram and gestational-development/consultation text
Sec. 3, new §502(hh)(2) · Economic Freedom — Prominent readable high-contrast display
Sec. 3, new §502(hh)(3)(A)–(F) · Economic Freedom — Defines abortion, covered drugs, fetus, fetal remains, packaging and waste, excluding miscarriage, ectopic/molar treatment and live-birth purposes
Sec. 3, new FDCA §502(hh) · Government Power — New federal misbranding conditions
Sec. 3, new FDCA §502(hh)(1)(A)–(C) · Economic Freedom — Abortion-drug packaging misbranded absent warning against flushing remains/waste, pictogram and gestational-development/consultation text
Sec. 3, new §502(hh)(2) · Economic Freedom — Prominent readable high-contrast display
Sec. 3, new §502(hh)(3)(A)–(F) · Economic Freedom — Defines abortion, covered drugs, fetus, fetal remains, packaging and waste, excluding miscarriage, ectopic/molar treatment and live-birth purposes
Sec. 3, new FDCA §502(hh) · Government Power — New federal misbranding conditions
Sec. 3, new FDCA §502(hh)(1)(A)–(C) · Economic Freedom — Abortion-drug packaging misbranded absent warning against flushing remains/waste, pictogram and gestational-development/consultation text
Sec. 3, new §502(hh)(2) · Economic Freedom — Prominent readable high-contrast display
Sec. 3, new §502(hh)(3)(A)–(F) · Economic Freedom — Defines abortion, covered drugs, fetus, fetal remains, packaging and waste, excluding miscarriage, ectopic/molar treatment and live-birth purposes
Sec. 3, new FDCA §502(hh) · Government Power — New federal misbranding conditions
SEC. 4. CATCH KIT AND DISPOSAL REQUIREMENTS.
Sec. 4(a)(1)–(4) · Individual Rights — Abortion-drug providers must provide collection kits/instructions, obtain receipt acknowledgment, accept returned remains and waste and arrange burial/cremation and disposal; patients affected but not expressly required to return remains
Sec. 4(a)–(e) · Property Rights — Regulates handling of biological material, not title or eminent domain
Sec. 4(a)(1)–(4) · Economic Freedom — Kit, acknowledgment and disposal duties
Sec. 4(a)(2) · Privacy and Due Process — Provider retains physical/electronic patient receipt acknowledgment
Sec. 4(a) · Government Power — HHS directs provider procedures
Sec. 4(a)(1)–(4) · Individual Rights — Abortion-drug providers must provide collection kits/instructions, obtain receipt acknowledgment, accept returned remains and waste and arrange burial/cremation and disposal; patients affected but not expressly required to return remains
Sec. 4(a)–(e) · Property Rights — Regulates handling of biological material, not title or eminent domain
Sec. 4(a)(1)–(4) · Economic Freedom — Kit, acknowledgment and disposal duties
Sec. 4(a) · Government Power — HHS directs provider procedures
Sec. 4(a)(1)–(4) · Individual Rights — Abortion-drug providers must provide collection kits/instructions, obtain receipt acknowledgment, accept returned remains and waste and arrange burial/cremation and disposal; patients affected but not expressly required to return remains
Sec. 4(a)–(e) · Property Rights — Regulates handling of biological material, not title or eminent domain
Sec. 4(a)(1)–(4) · Economic Freedom — Kit, acknowledgment and disposal duties
Sec. 4(a)(2) · Privacy and Due Process — Provider retains physical/electronic patient receipt acknowledgment
Sec. 4(a) · Government Power — HHS directs provider procedures
Sec. 4(a)(1)–(4) · Individual Rights — Abortion-drug providers must provide collection kits/instructions, obtain receipt acknowledgment, accept returned remains and waste and arrange burial/cremation and disposal; patients affected but not expressly required to return remains
Sec. 4(a)–(e) · Property Rights — Regulates handling of biological material, not title or eminent domain
Sec. 4(a)(1)–(4) · Economic Freedom — Kit, acknowledgment and disposal duties
Sec. 4(a) · Government Power — HHS directs provider procedures
Sec. 4(a)(1)–(4) · Individual Rights — Abortion-drug providers must provide collection kits/instructions, obtain receipt acknowledgment, accept returned remains and waste and arrange burial/cremation and disposal; patients affected but not expressly required to return remains
Sec. 4(a)–(e) · Property Rights — Regulates handling of biological material, not title or eminent domain
Sec. 4(a)(1)–(4) · Economic Freedom — Kit, acknowledgment and disposal duties
Sec. 4(a) · Government Power — HHS directs provider procedures
Sec. 4(a)–(e) · Property Rights — Regulates handling of biological material, not title or eminent domain
Sec. 4(b)(1)–(2) · Economic Freedom — Documentation identifies nearest receiving facility with contacts and approximate distance from patient address
Sec. 4(b)(2) · Privacy and Due Process — Address-dependent facility details
Sec. 4(a)–(e) · Property Rights — Regulates handling of biological material, not title or eminent domain
Sec. 4(b)(1)–(2) · Economic Freedom — Documentation identifies nearest receiving facility with contacts and approximate distance from patient address
Sec. 4(a)–(e) · Property Rights — Regulates handling of biological material, not title or eminent domain
Sec. 4(b)(1)–(2) · Economic Freedom — Documentation identifies nearest receiving facility with contacts and approximate distance from patient address
Sec. 4(b)(2) · Privacy and Due Process — Address-dependent facility details
Sec. 4(c)(1)–(2) · Individual Rights — Provider must accept returns even from nonpatients
Sec. 4(a)–(e) · Property Rights — Regulates handling of biological material, not title or eminent domain
Sec. 4(c)(1)–(2) · Economic Freedom — Accepts returns regardless of patient relationship
Sec. 4(c)(1)–(2) · Individual Rights — Provider must accept returns even from nonpatients
Sec. 4(a)–(e) · Property Rights — Regulates handling of biological material, not title or eminent domain
Sec. 4(c)(1)–(2) · Economic Freedom — Accepts returns regardless of patient relationship
Sec. 4(c)(1)–(2) · Individual Rights — Provider must accept returns even from nonpatients
Sec. 4(a)–(e) · Property Rights — Regulates handling of biological material, not title or eminent domain
Sec. 4(c)(1)–(2) · Economic Freedom — Accepts returns regardless of patient relationship
Sec. 4(d) · Individual Rights — Provider/kit-tampering violations carry imprisonment/fines
Sec. 4(a)–(e) · Property Rights — Regulates handling of biological material, not title or eminent domain
Sec. 4(d) · Economic Freedom — Up to five years imprisonment and $20,000–$150,000 fine per offense, or both, for covered dispensing without kit/documentation or tampering
Sec. 4(d) · Privacy and Due Process — Criminal penalties, without new special hearing or burden-of-proof rule
Sec. 4(d) · Government Power — Criminal fines/imprisonment
Sec. 4(a)–(e) · Property Rights — Regulates handling of biological material, not title or eminent domain
Sec. 4(e)(1)–(3) · Economic Freedom — Defines provider and kit components, separate leak-resistant containers, instructions, in-person returns and mail prohibition
Sec. 4(a)–(e) · Property Rights — Regulates handling of biological material, not title or eminent domain
Sec. 4(e)(1)–(3) · Economic Freedom — Defines provider and kit components, separate leak-resistant containers, instructions, in-person returns and mail prohibition
Sec. 4(a)–(e) · Property Rights — Regulates handling of biological material, not title or eminent domain
Sec. 4(e)(1)–(3) · Economic Freedom — Defines provider and kit components, separate leak-resistant containers, instructions, in-person returns and mail prohibition
Sec. 4(a)–(e) · Property Rights — Regulates handling of biological material, not title or eminent domain
Sec. 4(e)(1)–(3) · Economic Freedom — Defines provider and kit components, separate leak-resistant containers, instructions, in-person returns and mail prohibition
SEC. 5. RULE OF CONSTRUCTION.
Sec. 5 · Individual Rights — Existing emergency-treatment requirements preserved
Sec. 5 · Government Power — Preserves emergency care laws
SEC. 6. APPLICABILITY.
Sec. 6 · Government Power — Packaging rule applies to drugs packaged 180 days after enactment; no express delay for Sec. 4. No sunset
Findings source: bill-scores-v2-batch24-findings-2026-11-14.md. Highlights come only from that file; no finding, score, or provision was invented for this page.
What you can do
Contact your U.S. Representative and Senators about this bill.
Find your Representative Contact your Senators
Spot an error on this page? Report it.